Xalud Therapeutics (United States)
ORCID: 0000-0001-9117-5145Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 4 papers. Top paper: “RHOA signaling defects result in impaired axon guidance in iPSC-derived neurons from patients with tuberous sclerosis complex”.
Massimo M. Onesto, Alec J. McCann, Sarah K. Rempel, Jennifer Glass, David Neal Franz +2 more
Caitlin A. Short, Sarah K. Rempel, Timothy Catlett, Timothy M. Gómez, Massimo M. Onesto
Massimo M. Onesto, Sarah K. Rempel, Timothy Catlett, Timothy M. Gómez, Caitlin A. Short
Fikri Birey, Min-Yin Li, Omer Revah, Rebecca J. Levy, Mayuri Vijay Thete +11 more